Concepedia

Caili Xu

CX

Statistics

Publications

6

Citations

359

H-Index

6

Active since

2022

Affiliations

Fudan University(Current)

Obstetrics and Gynecology Hospital of Fudan University

Changhai Hospital

Second Military Medical University

Novartis (China)

Caili Xu is an author at Fudan University specializing in oncology, pharmacology, and molecular oncology.

Publications per year

2022–2025

6

Publications

6

NPASS database update 2023: quantitative natural product activity and species source database for biomedical research

Hui Zhao, Yuan Yang, Shuaiqi Wang et al. · Nucleic Acids Research · 2022 · 117 citations · Full text

, , +13

TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer

Caili Xu, Min Zhu, Qian Wang et al. · Journal of Nanobiotechnology · 2023 · 85 citations · Full text

, , +17

Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancer

Caili Xu, Xiting Huang, Qinchao Hu et al. · Biomedicine & Pharmacotherapy · 2024 · 68 citations · Full text

, , +16

Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer

Wenjing Xue, Caili Xu, Kaiqi Zhang et al. · Cell Death Discovery · 2024 · 41 citations · Full text

, , +17

Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8+ T cell and evading IL-18BP in preclinical models

Yanyang Nan, Min Zhu, Qian Wang et al. · Molecular Therapy · 2025 · 34 citations · Full text

, , +17

1–5 of 6